Restrictive Cardiomyopathy in Cats: Symptoms, Causes & Treatment
Restrictive cardiomyopathy in cats is a serious but rare heart disease with poor prognosis, median survival is only 30–69 days after heart failure onset.
Sources: PubMed Central, veterinary professional organizations, veterinary academic institution websites
Published: 2026-08
Last updated: 2026-07
This article is for informational purposes only and does not substitute professional veterinary advice. Always consult a licensed veterinarian for diagnosis and treatment.
Introduction
Restrictive cardiomyopathy (RCM) is a primary disease of the heart muscle in which the walls of the heart become abnormally stiff due to fibrosis (scarring of the muscle tissue) [1, 2]. Because the walls cannot relax properly, the ventricles struggle to fill with blood between beats, a problem known as diastolic dysfunction. This restriction of filling is what gives the disease its name.
RCM is one of the less common primary cardiomyopathies (diseases of the heart muscle itself) in cats, occurring much less frequently than hypertrophic cardiomyopathy (HCM), which is the most common feline heart disease [2, 3]. Despite its lower prevalence, RCM tends to behave aggressively and carries a poorer outlook.
On echocardiography (ultrasound imaging of the heart), the hallmark features are marked enlargement of the left atrium (the upper left chamber) or both atria, while the wall thickness of the left ventricle remains normal [1, 4, 2]. A restrictive filling pattern is seen on Doppler echocardiography (a type of ultrasound that measures blood flow), where blood flows rapidly into the stiff ventricle but decelerates just as quickly.
Veterinary cardiologists recognize two morphological forms of the disease [5, 6, 3]. The endomyocardial form (EMF-RCM) shows a distinct scar or fibrous band bridging the left ventricular cavity, often accompanied by inflammation. The myocardial form features diffuse fibrosis throughout the heart wall without a focal scar, but with pronounced atrial enlargement.
Clinically, RCM may be entirely asymptomatic in its early phase, or it may come to attention through signs of congestive heart failure (CHF) or arterial thromboembolism (ATE), a sudden blockage of a major artery by a blood clot [4, 2, 1]. The disease most often affects middle-aged to older cats, with a mean age of roughly 10 years at diagnosis, and most affected cats are mixed-breed domestic shorthairs [4, 2].
What this means for your cat: RCM is a stiffness problem, not a thickening problem. The heart muscle scars and cannot relax to fill with blood properly, which can lead to fluid backup in the lungs and dangerous blood clots.
Signs and Symptoms of Restrictive Cardiomyopathy
The earliest stage of RCM often produces no visible signs at all, many cats are diagnosed only after a vet hears something concerning during a routine exam or while investigating another problem [1, 2].
When symptoms do appear, the most common and dramatic sign is respiratory distress [4, 7]. Cats may breathe rapidly, with effort, or even through an open mouth. This happens because fluid leaks from the failing heart into the lungs (pulmonary edema) or into the space surrounding the lungs (pleural effusion), both of which make it hard to expand the chest. Owners sometimes notice their cat seems reluctant to lie down, or that the breathing has a visible abdominal component, a so-called "belly breath."
On veterinary examination, crackling sounds can often be heard through the stethoscope where fluid has accumulated in the lungs [4]. Pleural effusion can be substantial enough that the vet can detect muffled or dull sounds over part of the chest.
Less specific systemic signs are also common and may be the first clue an owner picks up on [7, 1]. These include lethargy, exercise intolerance, decreased appetite, weight loss, and withdrawal or hiding behavior. Ascites (fluid buildup in the abdomen) can develop in cats with right-sided heart failure, although this is less common than pleural effusion [2].
A particularly devastating presentation is arterial thromboembolism [1, 2]. A blood clot that forms in the enlarged left atrium can break loose and lodge in a distant artery, most often in the hindlimbs. Cats with ATE typically develop sudden hindlimb lameness or full paralysis, with cold, painful limbs, absent femoral pulses, and bluish nail beds. Some cats may faint (syncope) because of significant heart rhythm disturbances, though this is uncommon [1].
Clinical signs often begin subtly and worsen gradually over weeks to months [7], which means a vigilant owner and a thorough physical exam are sometimes the only way to catch the disease in its earlier stages.
Causes and Risk Factors
In most cases, no underlying cause of RCM is ever identified, the disease is considered idiopathic (of unknown origin) [1, 6, 3].
For the endomyocardial form, however, an infectious or inflammatory trigger has been proposed [2]. Many cats with EMF-RCM have evidence of endomyocarditis, an inflammatory condition of the heart's inner lining, and a 2018 study found evidence of Bartonella organisms in the endomyocardium of about half of affected cats, often together with interstitial pneumonia. This has led researchers to speculate that some cases may begin with an infection, but a definitive causal link has not been proven.
Unlike HCM, where several breed-related genetic mutations have been identified, no feline-specific genetic cause of RCM has been confirmed [2, 3]. A variant in the CSRP3 gene has been proposed as a possible biomarker, but its role in actually causing the disease remains unclear.
Taurine deficiency, once a common cause of dilated cardiomyopathy (DCM) in cats, is not associated with RCM [2]. Other possible contributors such as hyperthyroidism (overactive thyroid gland), systemic hypertension (high blood pressure), and prior myocardial infarction (heart attack) have been suggested, but direct evidence linking them to RCM is lacking.
There is no recognized breed predisposition, most cats diagnosed with RCM are mixed-breed domestic shorthairs [2, 4]. Age is the main risk factor: the disease is uncommon in young cats and is most often diagnosed in middle-aged to older individuals, with a mean age of around 10 years [4].
Stages and Types of Restrictive Cardiomyopathy
RCM is classified both by its morphological appearance and by the clinical stage of the disease, and understanding both helps guide treatment decisions.
Morphologically, veterinary cardiologists recognize two main types [5, 6, 3]. The endomyocardial form (EMF-RCM) features a grossly visible scar, often appearing as a dense band of fibrous tissue bridging the left ventricle, and is frequently associated with inflammatory cells [2]. The myocardial form consists of diffuse interstitial fibrosis (widespread microscopic scarring throughout the muscle) without a discrete scar; grossly the left ventricular wall looks normal, but the atria are markedly enlarged [4, 6].
For clinical staging, veterinarians most often use the ACVIM consensus staging system developed for feline cardiomyopathies [6, 5]. The stages run from A through D:
| Stage | Description |
|---|---|
| A | At-risk cats (by breed or family history) with no structural changes |
| B1 | Asymptomatic, with normal or only mildly enlarged atria |
| B2 | Asymptomatic, with moderate-to-severe left atrial enlargement (high risk for CHF or ATE) |
| C | Current or previous congestive heart failure or arterial thromboembolism |
| D | Heart failure that is refractory (no longer responding) to standard treatment |
The clinical presentations described earlier map neatly onto this system. Preclinical cats fall into Stage B; cats in active or previous heart failure or with a history of ATE fall into Stage C [5, 6].
What this means for your cat: Knowing the stage matters because treatment is stage-dependent. Catching a cat in Stage B2 allows for preventive treatment against blood clots, which is far more effective than treating a clot after it has formed.
Both forms of RCM can progress to CHF and ATE, but the endomyocardial form may carry a particular risk for intracardiac thrombus (blood clot formation inside the heart) because of blood stasis (sluggish flow) in the severely dilated left auricle [2]. The progression from B2 to C heralds the onset of life-threatening complications and is a critical pivot point in the disease [6, 2].
How Vets Diagnose Restrictive Cardiomyopathy
Diagnosis requires echocardiography, heart ultrasound, to confirm RCM, but the process begins with a thorough physical exam and imaging workup.
The diagnostic journey starts with a detailed history and physical examination [7, 6]. Auscultation (listening with a stethoscope) may reveal a gallop rhythm (an extra heart sound indicating stiff ventricular filling), a heart murmur, or an arrhythmia (abnormal heart rhythm). The vet will also look for signs of heart failure or thromboembolism.
Thoracic radiographs (chest X-rays) typically show generalized cardiomegaly (an enlarged heart silhouette) with a prominent bulge where the left atrium sits, along with pleural effusion or pulmonary edema in cats with CHF [1, 4, 2]. Radiographs alone cannot distinguish RCM from HCM, but they are extremely useful for identifying fluid in the lungs or chest.
Echocardiography is the gold standard and reveals the defining features of RCM [1, 4, 2]. These include marked left atrial or biatrial enlargement (often with a left-atrium-to-aorta ratio greater than 1.5), normal left ventricular wall thickness, and a restrictive mitral inflow Doppler pattern. This Doppler pattern shows a tall, rapid early filling wave (E wave) followed by rapid deceleration, reflecting the stiff ventricle that fills quickly and then abruptly stops accepting blood.
In the endomyocardial form, an experienced echocardiographer can often identify a characteristic fibrous band or shelf spanning the left ventricular cavity [2]. Identifying this structure sometimes requires advanced training, but when visible it strongly supports the diagnosis.
An electrocardiogram (ECG) is recommended to detect arrhythmias, which have been reported in 7–34% of cats with RCM [2, 4]. The presence and type of arrhythmia influences whether antiarrhythmic drugs are needed.
Cardiac biomarkers such as NT-proBNP (a blood marker of cardiac stretch and stress) can indicate significant myocardial stress, but they cannot differentiate RCM from other feline cardiomyopathies. Routine bloodwork, including a serum biochemistry panel (organ function tests), complete blood count, and total T4 (thyroid hormone) level, helps rule out hyperthyroidism and other concurrent illnesses that may complicate the picture [7].
Staging is finalized by correlating the clinical signs with the echocardiographic atrial size, placing each cat into B1, B2, or C [6, 5]. Identifying preclinical cats in Stage B2 is particularly important because starting clopidogrel thromboprophylaxis (a blood-thinning medication) at this stage can reduce the risk of a catastrophic thromboembolic event [6].
Treatment Options for Restrictive Cardiomyopathy
There is no cure for RCM, treatment is aimed at managing symptoms, preventing blood clots, and giving your cat the best possible quality of life for as long as possible [6].
Therapy is tailored to the disease stage. Cats in Stage B1 generally do not need medication but should be rechecked with echocardiography every 6–12 months [6]. Cats in Stage B2, asymptomatic but with significant left atrial enlargement, should be started on clopidogrel (18.75 mg per cat once daily) to reduce the risk of arterial thromboembolism [6, 2].
For cats in acute congestive heart failure (Stage C crisis), the priority is to stabilize breathing [6, 1]. This typically means oxygen supplementation, thoracocentesis (a chest tap to remove pleural fluid), and intravenous furosemide (a fast-acting diuretic that removes excess fluid). Once the cat is stable, chronic management includes an oral loop diuretic such as furosemide, titrated to the lowest effective dose, plus an angiotensin-converting enzyme (ACE) inhibitor such as enalapril or benazepril to reduce afterload (the resistance the heart has to pump against) and counter harmful neurohormonal activation [7, 1, 2].
Pimobendan, a drug that improves heart muscle contraction, may be considered as an adjunct, particularly if systolic function (the heart's pumping strength) appears reduced. However, no prospective clinical trials have evaluated pimobendan specifically for RCM, and its use in this setting is based on expert opinion.
Cats presenting with arterial thromboembolism are treated with opioid pain relief, supportive care, and antithrombotic medication [6, 2]. Thrombolytic therapy (clot-dissolving drugs) is rarely attempted because the risk of life-threatening bleeding complications is high. Clinically significant arrhythmias, such as atrial fibrillation with a rapid ventricular rate, may be managed with diltiazem; significant ventricular ectopy may warrant a beta-blocker like atenolol or sotalol [6, 2].
A low-sodium diet may be tried in cats with refractory or recurrent CHF signs, but should never compromise overall calorie intake [8]. Any concurrent condition, such as hyperthyroidism, must also be addressed [7].
Two practical at-home measures deserve special mention. First, regular monitoring of your cat's resting respiratory rate (when asleep or calm) provides an early warning of decompensation (worsening of heart failure). Second, follow-up echocardiography and renal panel monitoring (kidney blood tests) are essential to adjust therapy and detect disease progression.
Complications and Long-Term Risks
The biggest threats to a cat with RCM are recurrent congestive heart failure, blood clots, and dangerous arrhythmias [4, 9].
Congestive heart failure is the most common complication, often manifesting as recurrent pleural effusion and/or pulmonary edema [4, 9]. Cats that have experienced one episode of CHF are very likely to experience another, and each episode tends to be harder to control.
Arterial thromboembolism (ATE) is a particularly devastating complication [1, 2, 9]. It causes acute hindlimb paralysis, severe pain, and frequently leads to euthanasia. The risk is highest in cats with marked left atrial enlargement and spontaneous echocardiographic contrast (a smoky appearance inside the heart on ultrasound indicating sluggish blood flow).
Arrhythmias, including supraventricular tachycardias (fast rhythms originating in the upper chambers) and ventricular ectopy (abnormal beats from the lower chambers), can cause syncope and sudden death [2, 9].
As the disease advances, many cats eventually progress to refractory heart failure (Stage D), characterized by escalating diuretic resistance and persistent breathing difficulty [1, 7]. Concurrent kidney injury may be worsened by low cardiac output and diuretic or ACE inhibitor therapy, complicating long-term management. Cats can also develop cardiac cachexia, progressive weight loss and muscle wasting, from chronic disease and reduced nutrient intake [1].
Even with antithrombotic treatment, the risk of recurrent ATE remains if severe left atrial enlargement persists , [8].
Prognosis for Cats With Restrictive Cardiomyopathy
The overall prognosis for cats with RCM is guarded to poor, and once clinical signs appear the outlook becomes considerably worse [4, 1, 2].
Median survival after the onset of congestive heart failure is short: two separate studies reported median survival times of 30 days and 69 days, respectively [4, 2]. Cats that present with arterial thromboembolism have a grave immediate prognosis, and many are euthanized at the time of diagnosis [2].
For preclinical cats with significant left atrial enlargement (Stage B2), the risk of progression to heart failure or arterial thromboembolism is high; however, survival in this stage is not well documented, and some cats may remain asymptomatic for months to even years with appropriate monitoring.
The endomyocardial and myocardial forms appear to carry similarly poor prognoses once heart failure develops; no clear prognostic difference between the two subtypes has been established [2]. Factors associated with shorter survival include severe respiratory distress at presentation, marked left atrial enlargement, and the presence of pleural effusion [4].
Ultimately, RCM is a progressive and incurable disease. Even with optimal therapy, the long-term outlook is poor, and most affected cats die or are euthanized within the first year or two of diagnosis [1, 7]. Rarely, a cat may live longer than two to three years.
Living With a Cat With Restrictive Cardiomyopathy
Caring for a cat with RCM is a serious commitment, but attentive home care can extend quality time together [1, 7].
Administer all prescribed medications exactly as directed. If pilling is difficult, ask your vet about liquid formulations from a compounding pharmacy [1].
Monitor your cat's resting breathing rate at home when asleep or calm. A sustained rate above 30 breaths per minute may signal impending heart failure and warrants a call to your vet.
Minimize situations that excite or stress your cat. Avoid vigorous play and interactions that elevate the heart rate excessively [1]. Watch closely for any signs of thromboembolism, sudden lameness, dragging of the hindlimbs, crying in pain, or cold limb extremities, and seek emergency veterinary care immediately [1].
A low-sodium diet may be beneficial, but the priority is maintaining good food intake; never risk anorexia by forcing a diet change [8]. Attend all scheduled veterinary rechecks, which typically include echocardiography, blood pressure measurement, and renal function tests, so therapy can be adjusted as the disease evolves.
Provide a comfortable, quiet, and stable home environment with easy access to food, water, and litter boxes. Be prepared that, despite best care, RCM is progressive, and discuss quality-of-life parameters and end-of-life planning with your veterinarian ahead of time.
Lifelong commitment is required, including daily medication, frequent vet visits, and financial planning, but many cats can enjoy extended quality time with attentive home care [7].
Similar Conditions That Can Look Like Restrictive Cardiomyopathy
Several other feline heart diseases can mimic RCM, and accurate differentiation depends on echocardiography.
Hypertrophic cardiomyopathy (HCM) is the most common feline heart disease [6, 4]. In HCM, the left ventricular wall is thickened, whereas in RCM the wall thickness is normal. Echocardiography clearly distinguishes the two.
Dilated cardiomyopathy (DCM) involves a dilated, poorly contractile left ventricle [6, 2]. In RCM, chamber dimensions are usually normal and systolic function is preserved or only mildly reduced.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by right ventricular thinning and dilation, while RCM primarily affects the left atrium and ventricle, with the right side less involved [2, 6].
Left ventricular noncompaction (LVNC) is a rare anomaly with deep trabeculations (excessive muscular ridges) in the LV wall; wall thickness is normal, but the spongy appearance and lack of the marked atrial enlargement typical of RCM help differentiate it [6, 2].
Cardiomyopathy – nonspecific phenotype (formerly called unclassified) is a catch-all category for cats whose features do not fit strict criteria for any specific type [2, 6]. RCM has well-defined features, restrictive filling, biatrial enlargement, normal wall thickness, that should distinguish it.
Myocarditis, or inflammation of the heart muscle, can mimic RCM clinically, but it often has a more acute onset, may be associated with systemic illness, and sometimes improves with treatment of the underlying cause [2].
What We Still Don't Know: Gaps and Current Research
Despite decades of research, many fundamental questions about RCM remain unanswered.
The exact cause of the majority of RCM cases remains idiopathic, and the role of infectious triggers such as Bartonella is still under investigation and not yet proven [2]. No causative genetic mutation has been identified in cats; the CSRP3 variant requires further validation in larger populations to determine whether it is a disease-causing mutation, a biomarker, or simply an incidental finding [3, 2].
There are no randomized controlled trials evaluating the efficacy of pimobendan, spironolactone, or standardized antithrombotic protocols specifically in cats with RCM; current recommendations rely on expert consensus and extrapolation from HCM [2, 6]. The natural history of preclinical RCM (Stages B1 and B2) is unknown; large-scale prospective studies are needed to understand progression rates and identify reliable predictors of decompensation [5, 2].
Advanced imaging techniques, such as two-dimensional speckle-tracking echocardiography (2D-STE, a method that detects subtle heart muscle motion abnormalities), have shown early myocardial dysfunction in RCM, but whether these measures can predict survival or guide therapy requires prospective study [5]. Finally, the impact of early thromboprophylaxis on long-term survival and quality of life in cats with preclinical cardiomyopathy (Stage B2) has not been adequately assessed in controlled trials, representing a critical evidence gap , .
Connect with Other Cat Owners
Seeing how other owners manage the day-to-day realities of a restrictive cardiomyopathy diagnosis can be a real comfort, and these groups are a good place to ask the practical questions that don't always have clear answers online:
Just keep in mind that these groups are run by fellow cat owners sharing their own experiences rather than veterinary professionals, so it's always worth confirming any treatment or care advice with your own vet and double-checking that a group is still active before joining.
❓ Frequently Asked Questions
What is the prognosis for cats with restrictive cardiomyopathy?
The prognosis is guarded to poor. Once congestive heart failure develops, median survival is only about 30–69 days according to published studies. Cats that develop a blood clot (arterial thromboembolism) often have an even more immediate grave prognosis, with many euthanized at diagnosis. Preclinical cats may remain asymptomatic for months to years, but progression is common.
Can restrictive cardiomyopathy be cured?
No, RCM cannot be cured. The fibrosis (scarring) of the heart muscle is permanent, and there is no treatment known to reverse it. Care is focused on managing symptoms, preventing blood clots, slowing progression, and maintaining quality of life. Many cats, however, respond well to medications and enjoy meaningful quality time with attentive home care.
How do you treat cardiomyopathy in cats?
Treatment depends on the stage and symptoms. Cats with preclinical disease and significant left atrial enlargement usually receive clopidogrel to prevent blood clots. Cats in heart failure are treated with diuretics like furosemide and ACE inhibitors. Pimobendan may be added. Severe cases may need oxygen, chest taps, and hospitalization. Underlying conditions such as hyperthyroidism must also be addressed.
What causes restrictive cardiomyopathy in cats?
In most cases, the cause is unknown (idiopathic). Some researchers suspect that infections, particularly Bartonella organisms, may trigger the endomyocardial form, but this is not proven. Unlike hypertrophic cardiomyopathy, no breed-specific genetic mutation has been confirmed. Taurine deficiency causes dilated cardiomyopathy, not RCM, and the disease most often affects middle-aged to older mixed-breed cats.
At what age do cats get cardiomyopathy?
RCM most often affects middle-aged to older cats, with a mean age at diagnosis of roughly 10 years. It is uncommon in young cats, though rare cases have been reported in kittens as young as 4 months. Cardiomyopathies in general are largely diseases of adult and senior cats, so vigilance increases with age.
Are cats with cardiomyopathy in pain?
Cats with RCM are not usually in pain from the heart disease itself. However, cats that develop a blood clot (arterial thromboembolism) experience severe pain in the affected limb and require immediate opioid pain relief. Chronic disease can also cause discomfort through lethargy, weakness, and difficulty breathing, which treatment can substantially relieve.
References
- https://www.fentonrivervet.com/wp-content/uploads/CardiomyopathyFeline.pdf
- https://www.ncbi.nlm.nih.gov/pmc/articles/8723175/
- https://www.ncbi.nlm.nih.gov/pmc/articles/12756110/
- https://www.dvm360.com/view/prognosis-and-survival-in-cats-with-restrictive-cardiomyopathy
- https://www.ncbi.nlm.nih.gov/pmc/articles/8226601/
- https://everycat.org/cat-health/guidelines-for-the-classification-diagnosis-and-management-of-cardiomyopathies-in-cats
- https://wagwalking.com/cat/condition/restrictive-cardiomyopathy
- https://www.ncbi.nlm.nih.gov/pmc/articles/8642168/
- https://www.fecava.org/acvim-consensus-statement-guidelines-for-the-classification-diagnosis-and-management-of-cardiomyopathies-in-cats